Alholm, Z., Spinosa, D., Previs, R. A., Shuey, S. L., O’Malley, D. M., Randall, L., … Monk, B. J. (2021). SARS-CoV-2 vaccination in gynecologic oncology. European Journal of Gynaecological Oncology, 42(2), 402–404. https://doi.org/10.31083/j.ejgo.2021.02.2491

Alholm, Z., D. Spinosa, R. A. Previs, S. L. Shuey, D. M. O’Malley, L. Randall, B. Slomovitz, and B. J. Monk. “SARS-CoV-2 vaccination in gynecologic oncology.” European Journal of Gynaecological Oncology 42, no. 2 (April 15, 2021): 402–4. https://doi.org/10.31083/j.ejgo.2021.02.2491.

Alholm Z, Spinosa D, Previs RA, Shuey SL, O’Malley DM, Randall L, et al. SARS-CoV-2 vaccination in gynecologic oncology. European Journal of Gynaecological Oncology. 2021 Apr 15;42(2):402–4.

Alholm, Z., et al. “SARS-CoV-2 vaccination in gynecologic oncology.” European Journal of Gynaecological Oncology, vol. 42, no. 2, Apr. 2021, pp. 402–04. Scopus, doi:10.31083/j.ejgo.2021.02.2491.

Alholm Z, Spinosa D, Previs RA, Shuey SL, O’Malley DM, Randall L, Slomovitz B, Monk BJ. SARS-CoV-2 vaccination in gynecologic oncology. European Journal of Gynaecological Oncology. 2021 Apr 15;42(2):402–404.